In utero SFN also downregulated histone deacetylase 1 and increased histone acetylation in the mouse mammary tumors for reactivation of tumor suppressor genes (e.g., p16 and p53), and it may have governed the transcriptome changes affecting BRCA1 signaling pathway for anti-carcinogenesis [47]. This evidence concerns the gene TP53 and breast cancer.